CLINICAL_TRIALS
trial_result
· 2024-08-27
Clinical Trial Update: A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects [Phase 1]
Summary
A first-in-human single- and repeated-dose escalation study of SAR442501 in healthy adults has completed Phase 1.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Osteochondrodysplasia | Phase 1 | Status: COMPLETED